H Lundbeck Stock Price, News & Analysis
Company Description
H Lundbeck (OTC: HLUKF) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $4.9B.
HLUKF stock has declined 3.4% over the past year.
This page provides a comprehensive overview of HLUKF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
H Lundbeck (HLUKF) stock. Over the past 12 months, the stock has lost 3.4%. At a market capitalization of $4.9B, HLUKF is classified as a mid-cap stock with approximately 198.6M shares outstanding.
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HLUKF Company Profile & Sector Positioning
H Lundbeck (HLUKF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HLUKF often look at related companies in the same sector, including Alkermes Plc (ALKS), (EMBCV), Plus Prods Inc (PLPRF), Lantheus Holding (LNTH), and Regencell Bioscience Holdings Ltd (RGC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HLUKF's relative position within its industry.